Replimune Group, Inc. (REPL)
7.96
+0.20
(+2.58%)
USD |
NASDAQ |
Feb 12, 16:00
7.90
-0.06
(-0.75%)
After-Hours: 20:00
Replimune Group Market Cap : 657.28M for Feb. 12, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CorMedix, Inc. | 579.49M |
| Verastem, Inc. | 440.62M |
| Sarepta Therapeutics, Inc. | 1.828B |
| Anavex Life Sciences Corp. | 364.20M |
| Ocugen, Inc. | 459.88M |
Market Cap Related Metrics
| PEG Ratio | -0.1592 |
| Price to Book Value | 3.122 |
| Price | 7.96 |
| Earnings Yield | -45.01% |
| PEGY Ratio | -0.1592 |